• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膳食果糖与代谢综合征

Dietary Fructose and the Metabolic Syndrome.

机构信息

Research Program for Clinical and Molecular Medicine Unit, Diabetes and Obesity, University of Helsinki, 00029 Helsinki, Finland.

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, UK.

出版信息

Nutrients. 2019 Aug 22;11(9):1987. doi: 10.3390/nu11091987.

DOI:10.3390/nu11091987
PMID:31443567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6770027/
Abstract

: Consumption of fructose, the sweetest of all naturally occurring carbohydrates, has increased dramatically in the last 40 years and is today commonly used commercially in soft drinks, juice, and baked goods. These products comprise a large proportion of the modern diet, in particular in children, adolescents, and young adults. A large body of evidence associate consumption of fructose and other sugar-sweetened beverages with insulin resistance, intrahepatic lipid accumulation, and hypertriglyceridemia. In the long term, these risk factors may contribute to the development of type 2 diabetes and cardiovascular diseases. Fructose is absorbed in the small intestine and metabolized in the liver where it stimulates fructolysis, glycolysis, lipogenesis, and glucose production. This may result in hypertriglyceridemia and fatty liver. Therefore, understanding the mechanisms underlying intestinal and hepatic fructose metabolism is important. Here we review recent evidence linking excessive fructose consumption to health risk markers and development of components of the Metabolic Syndrome.

摘要

果糖是所有天然存在的碳水化合物中最甜的一种,在过去 40 年中,其消耗量急剧增加,如今在软饮料、果汁和烘焙食品中被广泛商业使用。这些产品构成了现代饮食的很大一部分,特别是在儿童、青少年和年轻人中。大量证据表明,果糖和其他含糖饮料的摄入与胰岛素抵抗、肝内脂质堆积和高甘油三酯血症有关。从长远来看,这些危险因素可能导致 2 型糖尿病和心血管疾病的发生。果糖在小肠中被吸收,并在肝脏中代谢,在肝脏中它刺激果糖分解、糖酵解、脂肪生成和葡萄糖生成。这可能导致高甘油三酯血症和脂肪肝。因此,了解肠道和肝脏果糖代谢的机制非常重要。在这里,我们回顾了最近的证据,这些证据将过量摄入果糖与健康风险标志物以及代谢综合征成分的发展联系起来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d763/6770027/4f696aaa25ad/nutrients-11-01987-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d763/6770027/4f696aaa25ad/nutrients-11-01987-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d763/6770027/4f696aaa25ad/nutrients-11-01987-g001.jpg

相似文献

1
Dietary Fructose and the Metabolic Syndrome.膳食果糖与代谢综合征
Nutrients. 2019 Aug 22;11(9):1987. doi: 10.3390/nu11091987.
2
Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.超重儿童的非酒精性脂肪肝疾病:果糖摄入和饮食模式的作用。
Nutrients. 2018 Sep 19;10(9):1329. doi: 10.3390/nu10091329.
3
Intestinal Fructose and Glucose Metabolism in Health and Disease.肠道果糖和葡萄糖代谢在健康和疾病中的作用。
Nutrients. 2019 Dec 29;12(1):94. doi: 10.3390/nu12010094.
4
Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease.果糖摄入、脂肪生成与非酒精性脂肪肝病。
Nutrients. 2017 Sep 6;9(9):981. doi: 10.3390/nu9090981.
5
Fructose metabolism and noncommunicable diseases: recent findings and new research perspectives.果糖代谢与非传染性疾病:最新研究发现与新的研究视角。
Curr Opin Clin Nutr Metab Care. 2018 May;21(3):214-222. doi: 10.1097/MCO.0000000000000460.
6
Effect of High Fructose-Induced Metabolic Syndrome on Tissue Vitamin E and Lipid Peroxide Levels in Rats.高果糖诱导的代谢综合征对大鼠组织维生素 E 和脂质过氧化物水平的影响。
J Nutr Sci Vitaminol (Tokyo). 2020;66(2):200-206. doi: 10.3177/jnsv.66.200.
7
The small intestine shields the liver from fructose-induced steatosis.小肠可防止肝脏发生果糖诱导的脂肪变性。
Nat Metab. 2020 Jul;2(7):586-593. doi: 10.1038/s42255-020-0222-9. Epub 2020 Jun 22.
8
Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis.果糖介导的与 NAFLD 发病机制相关的基因表达和表观遗传机制的作用。
Cell Mol Life Sci. 2020 Jun;77(11):2079-2090. doi: 10.1007/s00018-019-03390-0.
9
Dietary and commercialized fructose: Sweet or sour?膳食果糖与商业化果糖:是甜还是酸?
Int Urol Nephrol. 2017 Sep;49(9):1611-1620. doi: 10.1007/s11255-017-1544-8. Epub 2017 Feb 16.
10
[Molecular alterations induced by fructose and its impact on metabolic diseases].[果糖诱导的分子改变及其对代谢性疾病的影响]
Rev Med Inst Mex Seguro Soc. 2019 Jan 28;56(5):491-504.

引用本文的文献

1
The Effect of a Four-Month Low-Carbohydrate Diet on Visceral Adipose Tissue in Obese Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).为期四个月的低碳水化合物饮食对伴有代谢功能障碍相关脂肪性肝病(MASLD)的肥胖受试者内脏脂肪组织的影响。
Nutrients. 2025 Sep 8;17(17):2905. doi: 10.3390/nu17172905.
2
Impact of Fructose-Enhanced Solid and Soft Drink Diets on Metabolism, Physiology, and Gut Microbiome in Pregnant Rats.果糖强化固体饮料和软饮料饮食对妊娠大鼠代谢、生理及肠道微生物群的影响。
Biomed Res Int. 2025 Aug 13;2025:6902453. doi: 10.1155/bmri/6902453. eCollection 2025.
3
High-Fructose-Induced Salt-Sensitive Hypertension: The Potential Benefit of SGLT4 or SGLT5 Modulation.

本文引用的文献

1
Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD.新证据表明,载脂蛋白 C-III 抑制剂为降低残余 CVD 提供了新选择。
Curr Atheroscler Rep. 2019 May 20;21(8):27. doi: 10.1007/s11883-019-0791-9.
2
Intestinal lipogenesis: how carbs turn on triglyceride production in the gut.肠道脂肪生成:碳水化合物如何激活肠道中的甘油三酯生成。
Curr Opin Clin Nutr Metab Care. 2019 Jul;22(4):284-288. doi: 10.1097/MCO.0000000000000569.
3
Role of apolipoprotein C-III overproduction in diabetic dyslipidaemia.载脂蛋白 C-III 产生过多在糖尿病血脂异常中的作用。
高果糖诱导的盐敏感性高血压:SGLT4或SGLT5调节的潜在益处
Nutrients. 2025 Jul 30;17(15):2511. doi: 10.3390/nu17152511.
4
Factors associated with metabolic syndrome among adult residents in Dalian: a nested case-control study.大连成年居民中与代谢综合征相关的因素:一项巢式病例对照研究。
Front Endocrinol (Lausanne). 2025 Jul 17;16:1559176. doi: 10.3389/fendo.2025.1559176. eCollection 2025.
5
Does consumption of a high-fructose diet during pregnancy and lactation exacerbate the effects of maternal exposure to cadmium on development and metabolic function of mouse offspring?孕期和哺乳期食用高果糖饮食会加剧母体接触镉对小鼠后代发育和代谢功能的影响吗?
J Toxicol Environ Health A. 2025 Jul 30:1-24. doi: 10.1080/15287394.2025.2540862.
6
Fructose metabolism and its roles in metabolic diseases, inflammatory diseases, and cancer.果糖代谢及其在代谢性疾病、炎症性疾病和癌症中的作用。
Mol Biomed. 2025 Jun 23;6(1):43. doi: 10.1186/s43556-025-00287-2.
7
Effect of High Fructose Corn Syrup and Citric Acid in Broiler Diets on Performance, Gut pH, Immunity, Antioxidant Status and Some Blood Parameters.肉鸡日粮中高果糖玉米糖浆和柠檬酸对生产性能、肠道pH值、免疫力、抗氧化状态及一些血液参数的影响。
Vet Med Sci. 2025 Jul;11(4):e70436. doi: 10.1002/vms3.70436.
8
The effect of intensive resistance exercise and excessive fructose intake on metabolic and physiological responses.强化抗阻运动和过量摄入果糖对代谢及生理反应的影响。
Nutr Metab (Lond). 2025 May 23;22(1):50. doi: 10.1186/s12986-025-00943-y.
9
Multitissue single-cell analysis reveals differential cellular and molecular sensitivity between fructose and high-fat high-sucrose diets.多组织单细胞分析揭示了果糖与高脂肪高糖饮食之间不同的细胞和分子敏感性。
Cell Rep. 2025 May 27;44(5):115690. doi: 10.1016/j.celrep.2025.115690. Epub 2025 May 10.
10
Risk Factors Related to the Development of Nonalcoholic Fatty Liver: A Systematic Review.与非酒精性脂肪肝发生相关的危险因素:一项系统评价
Can J Gastroenterol Hepatol. 2025 Apr 15;2025:9964486. doi: 10.1155/cjgh/9964486. eCollection 2025.
Diabetes Obes Metab. 2019 Aug;21(8):1861-1870. doi: 10.1111/dom.13744. Epub 2019 May 8.
4
From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis.从糖到肝脂肪和公共健康:系统生物学驱动的非酒精性脂肪性肝病发病机制研究。
Proc Nutr Soc. 2019 Aug;78(3):290-304. doi: 10.1017/S0029665119000570. Epub 2019 Mar 29.
5
Long-Term Consumption of Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Mortality in US Adults.长期饮用含糖饮料和人工甜味饮料与美国成年人的死亡率风险。
Circulation. 2019 Apr 30;139(18):2113-2125. doi: 10.1161/CIRCULATIONAHA.118.037401.
6
Isocaloric Fructose Restriction Reduces Serum d-Lactate Concentration in Children With Obesity and Metabolic Syndrome.等热量果糖限制可降低肥胖合并代谢综合征患儿的血清 d-乳酸浓度。
J Clin Endocrinol Metab. 2019 Jul 1;104(7):3003-3011. doi: 10.1210/jc.2018-02772.
7
Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review.非酒精性脂肪性肝病与心脏:美国心脏病学会的现状评价。
J Am Coll Cardiol. 2019 Mar 5;73(8):948-963. doi: 10.1016/j.jacc.2018.11.050.
8
Obesity: global epidemiology and pathogenesis.肥胖症:全球流行病学和发病机制。
Nat Rev Endocrinol. 2019 May;15(5):288-298. doi: 10.1038/s41574-019-0176-8.
9
Sugar and Fatty Acids Ack-celerate Prophage Induction.糖和脂肪酸促进噬菌体的诱导。
Cell Host Microbe. 2019 Feb 13;25(2):175-176. doi: 10.1016/j.chom.2019.01.012.
10
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.非酒精性脂肪肝疾病是否会导致心血管疾病?现有知识和差距。
Atherosclerosis. 2019 Mar;282:110-120. doi: 10.1016/j.atherosclerosis.2019.01.029. Epub 2019 Jan 30.